Glaxosmithkline Stock News

Former Tesco boss Sir Dave Lewis is set to lead the £40bn separation of GlaxoSmithKline''s (GSK) consumer healthcare arm.

Compagnie Lombard Odier SCmA cut its position in shares of GlaxoSmithKline plc (NYSE:GSK) by 36.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 700 shares of the pharmaceutical companys stock after selling 400 shares during the period. Compagnie Lombard Odier SCmAs holdings in GlaxoSmithKline []

Related Stocks: NOKIA , RKT , 6301 , 7202 , FME , ABI , GSK , MRO , AM , CNHI , AKE , MB , DAU , SGRE , 3088 , SVS ,

During the recent session, GlaxoSmithKline plc (NYSE:GSK)s traded shares were 1.4 million, with the beta value of the company hitting 0.73. At the last check today, the stocks price was $43.67, reflecting an intraday gain of 0.03% or $0.01. The 52-week high for the GSK share is $43.71, that puts it down -0.09 from that GlaxoSmithKline plc (NYSE: GSK)s Stock Is Up 18.58% Since The Beginning Of The Year, Likely To Sustain The Trend In 2021 Read More »

The European Medicines Agency said Kineret, an immunosuppressive used to treat inflammatory conditions from Swedish firm Orphan Biovitrum, could "decrease lower airway damage, preventing development of severe respiratory failure". It said also that GlaxoSmithKline''s Xevudy drug had shown in a study that it "significantly reduces hospitalisation and deaths in patients with at least one underlying condition".

Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Biotech Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global biotech ingredients market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of 8.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor. Biotech ingredients are prepared using organisms like algae, yeast or bacteria that undergo deoxyribonucleic acid (DNA) editing to enhance the metabolic process of microbes. They are cost-effective and generate a low environmental impact than ingredients processed using petrochemicals. They act as a sustainable alternative to formulate plant-based extracts, which can counteract oxidative damages and slow down the aging process.

The Dendritic Cell and Tumor Cell Cancer Vaccine Market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic

The trading price of GlaxoSmithKline plc (NYSE:GSK) floating higher at last check on Wednesday, December 15, trading at $42.98, 0.19% higher than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

The EU has approved a booster dose of Johnson & Johnson''s COVID shot, but Sanofi and GlaxoSmithKline say their new shot could be longer in coming than expected. Edward Baran reports.

The Common Cancer-associated Antigens (CAAs) Vaccine research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and

Greenwood Capital Associates LLC lifted its stake in GlaxoSmithKline plc (NYSE:GSK) by 52.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,228 shares of the pharmaceutical companys stock after buying an additional 7,620 shares during the period. Greenwood Capital Associates LLCs []

Key Players covered in the Antiviral Drugs Market Research Report are Abbvie, Inc., Novartis AG, Gilead Sciences, Mylan N.V., GlaxoSmithKline, Merck & Co., Inc., Janssen Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Other key market players. Key Players covered in the Antiviral Drugs Market Research Report are Abbvie, Inc., Novartis AG, Gilead Sciences, Mylan N.V., GlaxoSmithKline, Merck & Co., Inc., Janssen Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Other key market players.

Data demonstrate sotrovimab, developed by Vir in conjunction with GlaxoSmithKline, continues to retain in vitro neutralizing activity against all tested variants of concern, including Omicron SAN FRANCISCO , Dec. 14, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc.

DUBLIN--(BUSINESS WIRE)--The "Marine Pharmaceuticals Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com''s offering. This report describes the global market size of Marine Pharmaceuticals from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For the geography segment, regional supply, demand, m